Found: 5
Select item for more details and to access through your institution.
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1344, doi. 10.3390/cancers15041344
- By:
- Publication type:
- Article
Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6240, doi. 10.3390/cancers14246240
- By:
- Publication type:
- Article
Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.
- Published in:
- Biomedicines, 2024, v. 12, n. 2, p. 394, doi. 10.3390/biomedicines12020394
- By:
- Publication type:
- Article
Inhibition of the Akt1-mTORC1 Axis Alters Venous Remodeling to Improve Arteriovenous Fistula Patency.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47542-5
- By:
- Publication type:
- Article
Author Correction: Inhibition of the Akt1-mTORC1 Axis Alters Venous Remodeling to Improve Arteriovenous Fistula Patency.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice